Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.
Knowing whether repurposing old drugs helps patients with cancer is important, but it will take a concerted investment by public entities such as the National Institutes of Health to make this happen.
How do scientists develop new treatments for disease? With Gleevec, a remarkable cancer drug, the approach was ... occurred in the first four weeks of therapy" (Druker et al., ...
Boron neutron capture therapy is being used ... drugs can make boron preferentially accumulate in tumour cells, compared with normal cells, with a ratio of about 3.5 to 1.0. 1 “If we find a new ...
The trial was designed to test the safety of the drug. The drug is the first to be trialled of a new family of ... a 62-year-old who was diagnosed with bowel cancer in 2012, was enrolled on ...
According to the National Cancer Institute, the drug, pembrolizumab, is "a type of targeted therapy drug called an immune checkpoint inhibitor (a type of immunotherapy)." Described as a monoclonal ...
A Dundalk-area man is the first person in Canada to receive a new, publicly funded treatment that better targets prostate cancer cells and is shown to prolong life.
A man's brain tumour has shrunk by half in a matter of weeks thanks to a new radioactive therapy. Paul Read ... under the scalp. The drug ATT001, which is given weekly for four to six weeks ...